financetom
Business
financetom
/
Business
/
United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing
Apr 23, 2024 1:53 PM

04:39 PM EDT, 04/23/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on April 19, 2024, sold 7,200 shares in United Therapeutics ( UTHR ) for $1,704,174. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 130 shares of the company, with 130 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000141588924011370/xslF345X03/form4-04232024_040401.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Digital publisher Arena Group's Q3 net income misses estimates
Digital publisher Arena Group's Q3 net income misses estimates
Nov 13, 2025
Overview * Arena Group Q3 2025 revenue declined, missing analyst expectations * Net income for Q3 2025 rose 73% yr/yr but missed analyst estimates * Adjusted EBITDA for Q3 2025 increased by 6.3% over Q3 2024 Outlook * Company emphasizes growth in data, AI, and e-commerce as future drivers * Arena Group ( AREN ) highlights audience volatility as a...
Biopharmaceutical company Precigen Q3 net loss widens 
Biopharmaceutical company Precigen Q3 net loss widens 
Nov 13, 2025
Overview * Precigen ( PGEN ) Q3 net loss widens significantly due to non-cash items like warrant liabilities * PAPZIMEOS receives FDA approval, launches as first treatment for adults with RRP * Company advances PAPZIMEOS commercialization with over 90% target institutions engaged * Cash, cash equivalents, and investments totaled $123.6 million as of September 30, 2025 Outlook * Company expects...
Tenon Medical Q3 revenue up 32% but misses estimates
Tenon Medical Q3 revenue up 32% but misses estimates
Nov 13, 2025
Overview * Tenon Medical ( TNON ) Q3 revenue grows 32% yr/yr to $1.17 mln, missing analysts' expectations * Net loss for Q3 2025 was $3.3 mln, slightly higher than Q3 2024 * Company raised $2.85 mln in PIPE financing post-Q3 to fund growth Outlook * Company plans SImmetry+ alpha launch in Q4 2025 * Tenon Medical ( TNON )...
Starz Entertainment slightly misses Q3 revenue estimates
Starz Entertainment slightly misses Q3 revenue estimates
Nov 13, 2025
Overview * Starz Q3 revenue slightly misses analyst expectations at $320.9 mln * Company reports Q3 net loss of $52.6 mln * U.S. OTT subscribers grew by 110,000 sequentially, reaching 12.3 mln Outlook * Management reiterates all previously provided 2025 outlook * Company aims to expand core audience with strong slate of originals Result Drivers * U.S. OTT GROWTH -...
Copyright 2023-2026 - www.financetom.com All Rights Reserved